Nouvelle déclaration d'incident
No de la demande: 2020-5913
Numéro de référence du titulaire d'homologation: 2020-CA-000404
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: CANADA
État: ONTARIO
ARLA No d'homologation 31724 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Hartz UltraGuard Rid Flea Dog Shampoo Fresh Scent
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Dog / Chien
Terrier - Fox Wire
1
Homme
7
37
lbs
Cutanée
>3 days <=1 wk / >3 jours <=1 sem
>24 hrs <=3 days / >24 h <=3 jours
Système
Persisted until death
Oui
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 16-Nov-2020, a 7 year old, 37 pound, neutered, male, Terrier - Fox Wire dog, in unknown condition, with no known concomitant medical conditions, was administered an unknown dose of Hartz UltraGuard Rid Flea Dog Shampoo Fresh Scent (Phenothrin (Sumithrin)) via the topical route by the animal owner. On 18-Nov-2020, the dog developed lethargy, vomiting, hemorrhagic diarrhea, shaking, anorexia and adipsia. The dog was evaluated by a veterinarian and prescribed metronidazole and discharged to the owner. It is unknown if any diagnostics were performed. On 20-Nov-2020, the signs persisted. Emergency veterinary evaluation was recommended. On 21-Nov-2020, the dog died at home. It is unknown if a necropsy was performed.
Mort
Assessment: This product contains phenothrin, a pyrethroid insecticide, at low concentration and has a wide margin of safety in dogs. Even if ingested, only mild oral or GI irritation would be expected. Adverse effects typically occur sooner than 2 days post-application. There severe and persistent signs reported progressing to death do not fit the toxicological profile of the product. Other causes should be considered including dietary indiscretion, pancreatitis, hemorrhagic gastroenteritis, inflammatory bowel disease, infectious diseases, and cancer. Without diagnostics, including necropsy, this case cannot be evaluated further. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.